Posted 3/14/2024, 9:47:00 AM
Nanotherapeutics Market Poised for Robust Growth Driven by Advances in Treating Brain Disorders and Cancer
- Market projected to reach $153 billion by 2030, growing at a CAGR of 8.7%
- Notable advances seen in neurology and oncology applications
- Increased efficiency in drug loading and greater bioavailability of hydrophobic drugs signal growth
- North America retains dominant position, bolstered by strong research infrastructure
- Key players include pharmaceutical and biotech companies like Pfizer, Johnson & Johnson, Novartis, and AstraZeneca